Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas March 28, 2019 - NASDAQ Companies 0 » View More News for March 28, 2019